Infectious Bursal Disease Virus antigens (IBDV antigens) (IBDV antigens)

Infectious Bursal Disease Virus (IBDV) antigens are the primary targets for immunotherapeutic and prophylactic strategies against Gumboro disease, a highly contagious and economically devastating infection in poultry (Müller et al., 2003). The virus, a member of the Birnaviridae family, possesses a bisegmented double-stranded RNA genome that encodes several structural and non-structural proteins, with the VP2 capsid protein serving as the major protective antigen containing critical neutralizing epitopes (Mahgoub et al., 2012). IBDV specifically targets and destroys IgM-bearing B-lymphocytes in the Bursa of Fabricius, leading to severe immunosuppression and increased susceptibility to secondary pathogens (van den Berg, 2000). Vaccine development focuses heavily on the VP2 protein, utilizing platforms ranging from traditional inactivated and live-attenuated viruses to modern recombinant viral vectors (e.g., Herpesvirus of Turkeys) and subunit vaccines. Effective targeting of these antigens is essential for overcoming the challenges posed by 'very virulent' (vvIBDV) and 'variant' strains that can bypass existing immunity (Jackwood, 2012). Monitoring the antigenic profile of the VP2 hypervariable region is a standard practice in veterinary medicine to ensure vaccine efficacy and flock health.

Other names

Gumboro disease virus antigensIBDV proteinsVP2 capsid proteinVP3 proteinVP4 proteaseVP1 RNA-dependent RNA polymerase

Vaccines targeting these antigens stimulate the host immune system to produce neutralizing antibodies, primarily directed against the hypervariable region of the VP2 protein, which prevents viral attachment and entry into precursor B-lymphocytes (Müller et al., 2003; van den Berg, 2000).